Caplan Mika, Bardeleben Carolyne, Dhawan Kanika, Plawat Rhea, Kufareva Irina, Trejo JoAnn
Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, California, USA.
Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.
J Biol Chem. 2025 May 21;301(7):110270. doi: 10.1016/j.jbc.2025.110270.
Mammalian α-arrestins are members of the same arrestin family as the ubiquitously expressed and extensively studied β-arrestins. Arrestins share common structural elements, including the conserved N- and C-arrestin-fold domains, polar core, finger loop, and C-terminal tail, all of which mediate protein-protein interactions. In β-arrestins, these domains enable the control of G protein-coupled receptor (GPCR) signaling and scaffolding interactions with various signaling proteins including c-Src. By contrast, the repertoire of α-arrestin scaffolding partners and regulatory mechanisms that control their interactions are not well-understood. α-arrestins differ considerably from β-arrestins in the C-terminal region; β-arrestins contain clathrin adaptor β-adaptin-binding sites, whereas α-arrestins harbor PPxY motifs, demonstrated to interact with WW domains of E3 ubiquitin ligases such as WWP2. Here we report the identification of a novel phosphorylation site, tyrosine (Y) 394, embedded in the C-terminal PPxY motif of α-arrestin ARRDC3. The Y394 site functions as a phospho-regulatory switch to enable distinct ARRDC3 binding partners and scaffolding functions. We found that ARRDC3 Y394 phosphorylation promotes interaction with c-Src via its SH2 domain, whereas the non-phosphorylated form binds to WWP2. Our results further show that ARRDC3 Y394 phosphorylation and c-Src SH2 domain-dependent interaction enables regulation of c-Src activity, whereas ARRDC3 Y394 phosphorylation disrupts WWP2 interaction and perturbs ARRDC3-dependent lysosomal trafficking of the GPCR, protease-activated receptor-1. Together, these findings indicate that ARRDC3 Y394 functions as a phospho-regulatory switch to enable selective binding to different partners that impact distinct scaffolding functions.
哺乳动物α-抑制蛋白与广泛表达且被深入研究的β-抑制蛋白属于同一抑制蛋白家族。抑制蛋白具有共同的结构元件,包括保守的N端和C端抑制蛋白折叠结构域、极性核心、指状环和C端尾巴,所有这些元件都介导蛋白质-蛋白质相互作用。在β-抑制蛋白中,这些结构域能够控制G蛋白偶联受体(GPCR)信号传导,并与包括c-Src在内的各种信号蛋白进行支架相互作用。相比之下,α-抑制蛋白支架伴侣的组成及其控制相互作用的调节机制尚不清楚。α-抑制蛋白在C端区域与β-抑制蛋白有很大差异;β-抑制蛋白含有网格蛋白衔接蛋白β-衔接蛋白结合位点,而α-抑制蛋白含有PPxY基序,已证明该基序可与E3泛素连接酶(如WWP2)的WW结构域相互作用。在此,我们报告了在α-抑制蛋白ARRDC3的C端PPxY基序中鉴定出一个新的磷酸化位点,即酪氨酸(Y)394。Y394位点作为一个磷酸化调节开关,可实现不同的ARRDC3结合伴侣和支架功能。我们发现,ARRDC3 Y394磷酸化通过其SH2结构域促进与c-Src的相互作用,而非磷酸化形式则与WWP2结合。我们的结果进一步表明,ARRDC3 Y394磷酸化和c-Src SH2结构域依赖性相互作用能够调节c-Src活性,而ARRDC3 Y394磷酸化会破坏与WWP2的相互作用,并干扰GPCR(蛋白酶激活受体-1)依赖于ARRDC3的溶酶体运输。总之,这些发现表明ARRDC3 Y394作为一个磷酸化调节开关,能够选择性地结合不同的伴侣,从而影响不同的支架功能。